There are 398 resources available
Expanding perspectives: Progress in treatment choice in HER2- aBC
Presenter: Veronique Dieras
Session: Pfizer Oncology - Broadening horizons in HER2- advanced breast cancer
Resources:
Webcast
Patient case study: how does local clinical practice vary for patients with brain metastases?
Presenter: Volkmar Müller
Session: Seagen - Treatment sequencing in HER2-positive metastatic breast cancer: from guidelines to clinical practice
Resources:
Webcast
Managing individual needs: Real-world evidence in HER2- aBC
Presenter: Michael Lux
Session: Pfizer Oncology - Broadening horizons in HER2- advanced breast cancer
Resources:
Webcast
Q&A, discussion and close
Presenter: Michael Lux
Session: Pfizer Oncology - Broadening horizons in HER2- advanced breast cancer
Resources:
Webcast
Which local factors influence treatment sequencing for HER2-positive MBC?
Presenter: Volkmar Müller
Session: Seagen - Treatment sequencing in HER2-positive metastatic breast cancer: from guidelines to clinical practice
Resources:
Webcast
Consistency of approach: how can we personalise and adapt treatment sequencing for patients with HER2-positive MBC?
Presenter: Volkmar Müller
Session: Seagen - Treatment sequencing in HER2-positive metastatic breast cancer: from guidelines to clinical practice
Resources:
Webcast
Q&A
Presenter: All Speakers
Session: Seagen - Treatment sequencing in HER2-positive metastatic breast cancer: from guidelines to clinical practice
Resources:
Webcast
Summary and session close
Presenter: Volkmar Müller
Session: Seagen - Treatment sequencing in HER2-positive metastatic breast cancer: from guidelines to clinical practice
Resources:
Webcast
Introduction by the Chairs
Presenter: Suzette Delaloge
Session: Keynote lecture: How shall our knowledge of cancer evolution transform breast oncology?
Resources:
Webcast
TROP2-targeted ADCs in breast cancer
Presenter: Aditya Bardia
Session: Antibody drug conjugates (ADCs) to treat breast cancer
Resources:
Slides
Webcast